Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 13.2810.3210.155.385.60

What is the latest Core EBITDA Margin ratio of JAGSONPAL PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of JAGSONPAL PHARMACEUTICALS is 13.28 based on Mar2023 Standalone results.
Year Core EBITDA Margin
Mar202313.28
Mar202210.32
Mar202110.15
Mar20205.38
Mar20195.60

How is Core EBITDA Margin of JAGSONPAL PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2023 13.28
28.68
Mar2022 10.32
1.67
Mar2021 10.15
88.66
Mar2020 5.38
-3.93
Mar2019 5.6 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹857.7 Cr -3.3% 9.6% -3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹370,757.0 Cr 1.6% -3.7% 60% Stock Analytics
CIPLA ₹109,559.0 Cr -2% -4.6% 49.9% Stock Analytics
DIVIS LABORATORIES ₹103,416.0 Cr -0.9% 4.2% 14.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,088.9 Cr -2.1% -0.9% 89.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,939.0 Cr -3.1% -4.7% 21.6% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

-3.3%

9.6%

-3%

SENSEX

-0.6%

-2.1%

18.4%


You may also like the below Video Courses